Brief: Cohbar Resumes Cb4211 Phase 1B Clinical Trial
07/07/2020 18:34
July 7 (Reuters) - CohBar Inc CWBR.O :
* COHBAR RESUMES CB4211 PHASE 1B CLINICAL TRIAL
Source text for Eikon: urn:newsml:reuters.com:*:nGNX8RqBDZ
Further company coverage: CWBR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CohBar
See all newsBrief: CohBar, Inc. Q2 EPS USD -1.49
Brief: Morphogenesis And CohBar Announce Positive Results From Phase 1B Trial Of IFX-HU2.0 Personalized Cancer Vaccine, In Checkpoint Inhibitor Resistant Advanced Merkel Cell Carcinoma (MCC) And Cutaneous Squamous Cell Carcinoma (CSCC)
U.S. STOCKS ON THE MOVE-Galecto, Pinterest, Standard Lithium
CohBar surges on merger agreement with Morphogenesis
U.S. STOCKS ON THE MOVE-Chevron, Broadcom, Williams-Sonoma